Outsized Funding in Early-Stage Biotech Points to Investor Confidence in Novel AI-Backed Oncology Tools 5 months ago ByJohnIn AI & DataInvestments
BioAge Labs Advances Aging-Biology Pipeline with Lead Candidate BGE-102, Eyes Phase 1 by Year-End 5 months ago ByJohnIn InnovationTop Stories
Pliant Therapeutics Cuts Staff Drastically After Phase 2b Trial Suspension Over Safety Signals 5 months ago ByJohnIn PeopleResearch UpdatesTop Stories
Pacibekitug Shows Deep, Durable Inflammation Reduction in Phase 2 Trial Among CKD Patients 5 months ago ByJohnIn Biopharma HighlightsClinical Trials
Game-Changing Clinical Trial Launches for Australia’s Second Deadliest Cancer 5 months ago ByJohnIn Breaking NewsDeals
ATH434 Shows Significant Promise for Multiple System Atrophy in Landmark Phase 2 Trials 5 months ago ByJohnIn Clinical TrialsTop Stories
Immunotherapy Duo Shows Major Promise in Early-Stage and Advanced Cancers 5 months ago ByJohnIn Breaking News
Pioneering CRISPR Therapy Saves Infant With CPS1 Deficiency: A Milestone for Personalised Medicine 5 months ago ByJohnIn Breaking News
Precision Medicine and Artificial Intelligence Leading Cancer Care Innovations in 2025 5 months ago ByJohnIn Breaking News
Key Advances in Cancer and Immunotherapy Highlighted at AACR Annual Meeting 2025 6 months ago ByJohnIn Industry ConferencesPeoplePharma Industry UpdatesTop Stories
New Hope in Rare Diseases: CBL-514 Shows Strong Results at World Orphan Drug Congress 6 months ago ByJohnIn Industry ConferencesInnovationPeople
Innovent, BriaCell and Pfizer Unveil Cancer Trial Pipeline Updates and Upcoming Data at ASCO 2025 6 months ago ByJohnIn Pharma Industry Updates
Trodelvy plus Keytruda Shows Promise in First-Line PD-L1+ Triple-Negative Breast Cancer 6 months ago ByJohnIn Clinical TrialsInnovationLeaders
New Phase III and Preclinical Data Announced 21 April 2025: HER2-Positive Breast Cancer & PROTAC Advances 6 months ago ByJohnIn Biopharma HighlightsBreakthroughsClinical Trials
New Approvals in April 2025 Signal Advances in Kidney Disease and Giant Cell Arteritis Treatment 6 months ago ByJohnIn FDA ApprovalsFeatured Analysis
